Results 211 to 220 of about 6,238 (230)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV. [PDF]

Infect Dis Ther
Binkley A, Zimmerman M, Maguire C.
europepmc   +1 more source

Improving patients' satisfaction through service digitalization: a cross-sectional study based on the theory of psychological empowerment. [PDF]

BMC Health Serv Res
Zhou GS, Shi SH, Qian QR, Zheng QY.
europepmc   +1 more source

Susceptibility to Lenacapavir Among Newly Diagnosed HIV-Positive Patients Followed Up in Mozambique That Presented With Primary Antiretroviral Resistance to Other Classes. [PDF]

J Med Virol
Sebastião CS, Bathy J, Nhampossa T, Santos A, Santos A, Miranda M, Manhiça NM, Bila R, Vubil D, Seabra S, O Martins MR, Giovanetti M, Gomes P, Pingarilho M, Abecasis AB, Pimentel V.   +15 more
europepmc   +1 more source

Prognostic Significance of Psoas Muscle Index in Unresectable Hepatocellular Carcinoma: Comparative Analysis of Lenvatinib and Atezolizumab Plus Bevacizumab. [PDF]

J Clin Med
Shigefuku R, Iwasa M, Tanaka H, Tsukimoto M, Tamai Y, Fujiwara N, Yoshikawa K, Tameda M, Ogura S, Nakagawa H.   +9 more
europepmc   +1 more source

Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. [PDF]

Paediatr Drugs
Kamphuis AEM, Bamford A, Tagarro A, Cressey TR, Bekker A, Amuge P, Mujuru HA, Ndongo FA, Diack A, Compagnucci A, Lallemant M, Colbers A, Turkova A.   +12 more
europepmc   +1 more source

Frontline evaluation: Atezolizumab-bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up-to-seven criteria. [PDF]

Cancer Med
Kimura M, Nishikawa K, Imamura J, Kimura K.   +3 more
europepmc   +1 more source

Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review). [PDF]

Am J Cancer Res
Ye G, Ye M, Jin X.
europepmc   +1 more source